Libra Therapeutics

Libra Therapeutics Focuses on Developing Novel Disease-Modifying Therapies That Can Restore Cellular Balance Disrupted in Neurodegenerative Diseases. These Include Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease, All of Which Are Characterized by Cellular Imbalance Caused by the Production of Neurotoxic Proteins and Reduced Clearance Rates. The Company’s Therapeutic Platform Has a Unique Advantage in Discovering and Developing Small Molecule Drugs with Distinct Molecular Approaches That Can: (1) Enhance Autophagy to Accelerate the Clearance of Toxic Proteins; (2) Reduce the Production of Neurotoxic Proteins.